Development, Reliability and Validity of the Telerehabilitation Usability Questionnaire- TrUQ
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05970939 |
Recruitment Status :
Not yet recruiting
First Posted : August 2, 2023
Last Update Posted : August 3, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Neurological Disease | Other: Development of the Telerehabilitation Usability Questionnaire |
Study Type : | Observational |
Estimated Enrollment : | 60 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Official Title: | Development, Reliability and Validity of the Telerehabilitation Usability Questionnaire- TrUQ in Neurological Diseases |
Estimated Study Start Date : | July 28, 2023 |
Estimated Primary Completion Date : | August 28, 2023 |
Estimated Study Completion Date : | August 28, 2023 |
Group/Cohort | Intervention/treatment |
---|---|
Telerehabilitation Usability
Telerehabilitation Usability Group
|
Other: Development of the Telerehabilitation Usability Questionnaire
This study will be examined the development, validity, and reliability of the Telerehabilitation Usability Questionnaire in patients with MS. |
- Telerehabilitation Usability Questionnaire in patients with Neurological disease [ Time Frame: Baseline ]Patients get a minimum of 0 points (best condition) and a maximum of 4 points (worst condition) for each question on this scale
- Telerehabilitation Usability Questionnaire in patients with Neurological disease-Second [ Time Frame: he second assessment will be conducted after the one week ]Patients get a minimum of 0 points (best condition) and a maximum of 4 points (worst condition) for each question on this scale
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 80 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Voluntarily participate in research to accept
- Mini-Mental Test score more than or equal 24
- Previously receiving physical therapy through telerehabilitation
Exclusion Criteria:
- Any visual, hearing, and perception problems that may affect the answering the questionnaire items
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05970939
Contact: Kader Eldemir | +9 0452 226 52 48 | fztkader2015@gmail.com |
Turkey | |
Gazi University | |
Ankara, Turkey |
Publications:
Responsible Party: | Kader Eldemir, principal investigator, T.C. ORDU ÜNİVERSİTESİ |
ClinicalTrials.gov Identifier: | NCT05970939 |
Other Study ID Numbers: |
ND-Development-TrUQ |
First Posted: | August 2, 2023 Key Record Dates |
Last Update Posted: | August 3, 2023 |
Last Verified: | August 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Multiple Sclerosis Parkinson Disease Stroke Usability Telerehabilitation |
Nervous System Diseases |